AVBP
Price
$20.52
Change
+$0.90 (+4.59%)
Updated
Jan 9, 04:59 PM (EDT)
Capitalization
809.94M
75 days until earnings call
Intraday BUY SELL Signals
ELVN
Price
$25.97
Change
+$2.72 (+11.70%)
Updated
Jan 9, 04:59 PM (EDT)
Capitalization
1.38B
61 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AVBP vs ELVN

Header iconAVBP vs ELVN Comparison
Open Charts AVBP vs ELVNBanner chart's image
ArriVent BioPharma
Price$20.52
Change+$0.90 (+4.59%)
Volume$13.72K
Capitalization809.94M
Enliven Therapeutics
Price$25.97
Change+$2.72 (+11.70%)
Volume$158.03K
Capitalization1.38B
AVBP vs ELVN Comparison Chart in %
AVBP
Daily Signal:
Gain/Loss:
ELVN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AVBP vs. ELVN commentary
Jan 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVBP is a Hold and ELVN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 10, 2026
Stock price -- (AVBP: $19.62 vs. ELVN: $23.25)
Brand notoriety: AVBP and ELVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVBP: 58% vs. ELVN: 1106%
Market capitalization -- AVBP: $809.94M vs. ELVN: $1.38B
AVBP [@Biotechnology] is valued at $809.94M. ELVN’s [@Biotechnology] market capitalization is $1.38B. The market cap for tickers in the [@Biotechnology] industry ranges from $119.17B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVBP’s FA Score shows that 1 FA rating(s) are green whileELVN’s FA Score has 1 green FA rating(s).

  • AVBP’s FA Score: 1 green, 4 red.
  • ELVN’s FA Score: 1 green, 4 red.
According to our system of comparison, both AVBP and ELVN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVBP’s TA Score shows that 4 TA indicator(s) are bullish while ELVN’s TA Score has 5 bullish TA indicator(s).

  • AVBP’s TA Score: 4 bullish, 6 bearish.
  • ELVN’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, ELVN is a better buy in the short-term than AVBP.

Price Growth

AVBP (@Biotechnology) experienced а -2.49% price change this week, while ELVN (@Biotechnology) price change was +50.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.49%. For the same industry, the average monthly price growth was -0.45%, and the average quarterly price growth was +47.36%.

Reported Earning Dates

AVBP is expected to report earnings on Mar 26, 2026.

ELVN is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Biotechnology (+3.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELVN($1.38B) has a higher market cap than AVBP($810M). ELVN YTD gains are higher at: 50.974 vs. AVBP (-2.485). ELVN has higher annual earnings (EBITDA): -111.97M vs. AVBP (-162.42M). ELVN has more cash in the bank: 478M vs. AVBP (300M). AVBP has less debt than ELVN: AVBP (56K) vs ELVN (387K). AVBP (0) and ELVN (0) have equivalent revenues.
AVBPELVNAVBP / ELVN
Capitalization810M1.38B59%
EBITDA-162.42M-111.97M145%
Gain YTD-2.48550.974-5%
P/E RatioN/AN/A-
Revenue00-
Total Cash300M478M63%
Total Debt56K387K14%
FUNDAMENTALS RATINGS
ELVN: Fundamental Ratings
ELVN
OUTLOOK RATING
1..100
78
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AVBPELVN
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 19 days ago
83%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 10 days ago
89%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AVBP
Daily Signal:
Gain/Loss:
ELVN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCGMX20.760.07
+0.34%
NYLI PineStone Global Equity Class R6
MUHLX75.860.06
+0.08%
Muhlenkamp
OASGX12.92-0.01
-0.08%
Optimum Small-Mid Cap Growth A
DWGCX14.25-0.08
-0.56%
American Funds Dvlpg Wld Gr&Inc C
MEMRX38.26-0.30
-0.78%
MFS Emerging Markets Equity R1

AVBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVBP has been loosely correlated with CRNX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if AVBP jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVBP
1D Price
Change %
AVBP100%
-0.10%
CRNX - AVBP
50%
Loosely correlated
-0.19%
DNLI - AVBP
50%
Loosely correlated
+0.71%
XNCR - AVBP
50%
Loosely correlated
-5.08%
SYRE - AVBP
49%
Loosely correlated
-2.93%
ELVN - AVBP
48%
Loosely correlated
+50.29%
More

ELVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELVN has been loosely correlated with NUVL. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ELVN jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELVN
1D Price
Change %
ELVN100%
+50.29%
NUVL - ELVN
51%
Loosely correlated
-3.89%
DNLI - ELVN
49%
Loosely correlated
+0.71%
NRIX - ELVN
45%
Loosely correlated
+0.76%
ORIC - ELVN
44%
Loosely correlated
-2.65%
MLTX - ELVN
44%
Loosely correlated
+27.02%
More